NCT07804602

Brief Summary

The goal of this interventional clinical trial is to test an an app, PL4Y, installed on a mobile smartphone to see if it can help participants aged 18-29 years who have HIV achieve success with their HIV care and feel supported by their clinic community. The first 6 months will be standard of care, after which participants will continue to meet virtually with their health care providers and will also be provided with and taught how to use the app. The standard of care clinic visits will continue as before and virtual visits using the app will be started and continue for abot 18 months. Adherence to medications Appointment reminders Provide secure communication with providers Provide a support group in \[describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers\]. The main question\[s\] it aims to answer \[is/are\]: \[primary hypothesis or outcome measure 1\]? \[primary hypothesis or outcome measure 2\]? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
49mo left

Started Apr 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 4, 2026

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2027

Expected
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2031

1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2031

Last Updated

September 4, 2026

Status Verified

August 1, 2026

Enrollment Period

4 years

First QC Date

August 31, 2026

Last Update Submit

August 31, 2026

Conditions

Keywords

Communication with providersSmartphone AppAnonymous Virtual chat groupMedication reminders

Outcome Measures

Primary Outcomes (1)

  • Virologic Suppression

    HIV-1 Plasma RNA level \<200 copies/ml at 12 months

    Baseline to 12 months (+/- 3 months)

Secondary Outcomes (5)

  • Patient Health Questionnaire-9 (PHQ-9)

    Baseline to Study End (approximately 18 months)

  • HIV Stigma Scale Survey (HIVSS)

    Baseline to Study End (approximately 18 months)

  • National Institute of Drug Abuse (NIDA) - Modified ASSIST

    Baseline to study end (approximately 18 months)

  • System Usability Survey

    Month 12 and Month 18

  • HIV Care Engagement

    Baseline through end of study, measured at each study time point (baseline, 6mos, 12 mos, 18 mos)

Study Arms (1)

mHealth Intervention group

EXPERIMENTAL

18-29yos with HIV who are in care in one of the participating clinics.

Behavioral: PositiveLinks for Youth Smartphone App

Interventions

PL4Y, a smartphone application (app), is a clinic-based multimodal intervention designed by and for youth living with HIV, including daily adherence assessment, appointment reminders, secure messaging with clinic providers, and an asynchronous, anonymized virtual support group.

Also known as: PL4Y
mHealth Intervention group

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • yo living with HIV
  • Attending at least one in-person visit in the clinic site of enrollment in the past 12 mos,
  • English speaking
  • Able to participate in the informed consent process.
  • Access to a personal smartphone with a data plan capable of supporting the PL4Y app. The phone must be password protected and not shared with others for confidentiality purposes.
  • Interviews only- A stakeholder in one of the network clinics
  • years or older
  • able to participate in the informed consent process

You may not qualify if:

  • They cannot provide consent
  • Unwilling or unable to complete virtual study visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Texas Health Science Center San Antonio

San Antonio, Texas, 78229, United States

Location

University of Texas San Antonio Health Campus

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Barbara Taylor, MD, MS

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Barbara Taylor, MD, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Type 1 hybrid study. Staircase design is a particular variation of the incomplete stepped-wedge design.It allows for phased implementation of the intervention across all participating clusters in a staggered fashion, ensuring all clusters receive the intervention. A cluster serves both as its control, as it spends time under both control and intervention conditions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 31, 2026

First Posted

September 4, 2026

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

March 31, 2031

Study Completion (Estimated)

April 1, 2031

Last Updated

September 4, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

In an effort to protect your privacy, the study staff will use code numbers instead of participant name, to identify any health information. Numbers will be used on any photocopies of your records, and other study materials containing health information that are sent outside the clinic the participant attends for review or testing. If the results of this study are reported in medical journals or at meetings, participants will not be identified.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After study closure, data analysis and publication of summary results in ClinicalTrials.gov and a peer-review journal.

Locations